Announcements Trials
Browse Landscape

Phase

Phase NA 14Phase EARLY_PHASE1 2Phase 1 2Phase 2 1

Status

Completed 2

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Gynecologic 1

Conditions

Tobacco Use Cessation 1Smoking Cessation 1Endometrial Neoplasms 1

Interventions

Cyclophosphamide 416Radiotherapy 276fludarabine 238Gemcitabine 211Cisplatin 203Nivolumab 184pembrolizumab 183Paclitaxel 176Carboplatin 168Magnetic Resonance Spectroscopy 166fludarabine phosphate 156Irinotecan 135Bevacizumab 133Cytarabine 128Specimen Handling 124Capecitabine 124Temozolomide 123Radiosurgery 118Docetaxel 116Biopsy 116Ipilimumab 113Dexamethasone 113Radiation 111Oxaliplatin 110Fluorouracil 110Rituximab 108Etoposide 108Filgrastim 99Lenalidomide 98Everolimus 96

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Phase 1 × OTHER × Focus Groups × Clear all
NCT04474184 2023-11-18

Development of a New Early Detection Test to Reduce Racial Disparities in Endometrial Cancer (EC) Death Rates

Mayo Clinic

Phase 1 Completed
33 enrolled
Gynecologic

Endometrial Neoplasms

NCT00513097 2017-11-06

Curbing Tobacco Use in Suburban and Rural Schools

M.D. Anderson Cancer Center

Phase 1 Completed
1,289 enrolled

Smoking Cessation, Tobacco Use Cessation

Data powered by HemOnc (CC BY 4.0) Colophon âš¡